About this Research Topic
This Research Topic aims to deepen the knowledge on cognitive and neuropsychological symptoms in NeuroCOVID syndrome and highlight the latest research relevant for the prevention and management of cognitive deficits related to post-acute COVID-19 syndrome. Our goal is to improve the knowledge of the risk factors and physiopathology of the NeuroCovid cognitive deficits and other neurological manifestations, by raising the discussion on the psychosocial involvement as well as on the predictive value of objective neurological biomarkers. Ultimately, this Research Topic could be useful, precious, and practical for both researchers and clinicians in the diagnosis and person-centered care management of patients.
We welcome the submission of any type of manuscript supported by the journal (including Original Research, Brief Research Report, Review, etc.) related to the following themes:
• The physiopathology of PASC cognitive and neurological manifestations at the anatomic, cellular, and molecular levels.
• Brain anatomy of the related central nervous system structures implicated in PASC cognitive dysfunctions.
• The predictive value of objective neurological biomarkers, such as serum or CSF biomarkers, PET or SPECT scans, and functional MRI measures of neuronal lysis and cerebral metabolism.
• The prevalence, duration, and management of cognitive deficits related to PASC.
• Risk factors related to neuropsychological involvement.
• Cognitive repercussions in neurologically vulnerable populations (aging, psychiatric disorders, neurodevelopmental disorders, dementia, etc.).
Prof. Ludivine Chamard-Witkowski acts as Principal Investigator in clinical trials funded by Cassava Sciences and Merck group. Dr. Caroline Jose is co-author on a patent on Local anesthetics and use thereof in cancer (European Patent N.13306023.6, 08/2013) and she is founder and owner of the translation services company AntonymeRedaction©. Prof. Thorsten Rudroff declares no competing interests with regard to the Research Topic subject.
Keywords: SARS-CoV-2, post-Covid, PASC, NeuroCOVID syndrome, cognitive symptoms, dementia
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.